FDA Inspection 1216508 — Accuon Labs, Inc

Accuon Labs, Inc — FEI 3014660411

The FDA completed an inspection of Accuon Labs, Inc on Aug 31, 2023 in Hauppauge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 31, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hauppauge, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.